United States Cardiac Arrhythmia Monitoring Devices Market Insight
Published: 10 June 2026 | Report Format: Electronic (PDF)
The United States Cardiac Arrhythmia Monitoring Devices Market is projected to grow at a CAGR of 7.24%, driven by increasing cardiovascular disease prevalence, rising arrhythmia cases, expanding remote patient monitoring, wearable technology advancements, favorable reimbursement policies, and ongoing digital healthcare innovation.
United States Cardiac Arrhythmia Monitoring Devices Market Insights Forecasts to 2035
- The United States Cardiac Arrhythmia Monitoring Devices Market Size Was Estimated at USD 3.9 Billion in 2025
- The Market Size is Expected to Grow at a CAGR of around 7.24% from 2025 to 2035
- The United States Cardiac Arrhythmia Monitoring Devices Market Size is Expected to Rise Around USD 7.9 Billion by 2035
Notable Insights for the United States Cardiac Arrhythmia Monitoring Devices Market
- Segmentation on the basis of Device Type indicates that Wearable Cardiac Monitoring Devices hold the dominant position in the United States Cardiac Arrhythmia Monitoring Devices Market in 2025 with a market share of nearly 41% due to increasing demand for continuous monitoring, patient convenience, and integration with digital healthcare platforms.
- Segmentation on the basis of End User indicates that Hospitals & Cardiac Centers hold the dominant position in the market in 2025 with a market share of around 47% owing to high patient volumes, availability of specialized cardiac care services, and increasing utilization of advanced diagnostic technologies.
- Worldwide projected revenue of Medtronic plc in fiscal year 2025 is expected to benefit from growing demand for implantable cardiac monitors, remote monitoring solutions, and cardiac rhythm management technologies.
Download the eBook (ToC)
- Rising adoption of telecardiology services, artificial intelligence-enabled cardiac diagnostics, and long-term ambulatory monitoring devices is expected to drive market growth while improving early detection, treatment outcomes, and patient management.
Why Buy This Report
- Gives an in-depth analysis of the impact of cardiovascular disease prevalence, remote patient monitoring adoption, healthcare digitization, and technological advancements on the United States Cardiac Arrhythmia Monitoring Devices Market growth.
- Provides strategic insights regarding innovations such as AI-powered arrhythmia detection, cloud-based cardiac monitoring platforms, wireless ECG technologies, implantable loop recorders, and wearable health monitoring devices.
- Assists stakeholders in analyzing competitive benchmarking, regulatory developments, reimbursement trends, product innovation strategies, and expansion opportunities among leading medical device manufacturers.
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the United States Cardiac Arrhythmia Monitoring Devices Market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in United States Cardiac Arrhythmia Monitoring Devices Market
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corporation
- GE HealthCare Technologies Inc.
- Koninklijke Philips N.V.
- iRhythm Technologies, Inc.
- Biotronik SE & Co. KG
- Baxter International Inc. (Hillrom)
- AliveCor, Inc.
- Cardiac Insight Inc.
Recent Developments:
- In 2025, leading manufacturers expanded their portfolios of AI-enabled cardiac monitoring solutions to improve arrhythmia detection accuracy and support remote patient management.
- In 2025, healthcare providers increased adoption of wearable ECG patches and cloud-connected monitoring platforms to enhance long-term cardiac rhythm monitoring and reduce hospital readmissions.
Market Segmentation:
United States Cardiac Arrhythmia Monitoring Devices Market, By Device Type
- Holter Monitors
- Event Monitors
- Implantable Loop Recorders
- Mobile Cardiac Telemetry Devices
- Wearable Cardiac Monitoring Devices
United States Cardiac Arrhythmia Monitoring Devices Market, By Technology
- AI-Based Arrhythmia Detection Systems
- Wireless ECG Monitoring
- Cloud-Based Remote Monitoring Platforms
- Mobile Health (mHealth) Integration
- Continuous Cardiac Monitoring Technologies
United States Cardiac Arrhythmia Monitoring Devices Market, By End User
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers
- Diagnostic Clinics
- Home Healthcare Settings
- Research & Academic Institutions
United States Cardiac Arrhythmia Monitoring Devices Market, By Application
- Atrial Fibrillation Monitoring
- Bradycardia Detection
- Tachycardia Monitoring
- Post-Stroke Cardiac Monitoring
- General Cardiac Rhythm Assessment
Expert Views:
The United States Cardiac Arrhythmia Monitoring Devices Market is expected to experience robust growth owing to the increasing burden of cardiovascular disorders, rising demand for continuous and remote patient monitoring, and growing adoption of digital healthcare solutions. Advancements in wearable technologies, AI-driven cardiac diagnostics, cloud-connected monitoring systems, and implantable monitoring devices are expected to enhance early diagnosis, improve patient outcomes, and support long-term market growth across the United States healthcare sector.
Author: Govind and Krishna By Spherical Insights and Consulting